التفاصيل البيبلوغرافية
| العنوان: |
A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators. (Spanish) |
| المؤلفون: |
Fang Tang, Xiaoshuai Zhang, Bicheng Zhang, Bo Zhu, Jun Wang |
| المصدر: |
Journal of Medical Virology; Jan2022, Vol. 94 Issue 1, p131-140, 10p |
| مصطلحات موضوعية: |
COVID-19, NEUTROPHIL lymphocyte ratio, BLOOD urea nitrogen, LACTATE dehydrogenase, TREATMENT effectiveness |
| مستخلص: |
Introduction: The coronavirus disease 2019 (COVID-19) has quickly become a global threat to public health, and it is difficult to predict severe patients and their prognosis. Here, we intended developing effective models for the late identification of patients at disease progression and outcome. Methods: A total of 197 patients were included with a 20-day median follow-up time. We first developed a nomogram for disease severity discrimination, then created a prognostic nomogram for severe patients. Results: In total, 40.6% of patients were severe and 59.4% were non-severe. The multivariate logistic analysis indicated that IgG, neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase, platelet, albumin, and blood urea nitrogen were significant factors associated with the severity of COVID-19. Using immune response phenotyping based on NLR and IgG level, the logistic model showed patients with the NLRhiIgGhi phenotype are most likely to have severe disease, especially compared to those with the NLRloIgGlo phenotype. The C-indices of the two discriminative nomograms were 0.86 and 0.87, respectively, which indicated sufficient discriminative power. As for predicting clinical outcomes for severe patients, IgG, NLR, age, lactate dehydrogenase, platelet, monocytes, and procalcitonin were significant predictors. The prognosis of severe patients with the NLRhiIgGhi phenotype was significantly worse than the NLRloIgGhi group. The two prognostic nomograms also showed good performance in estimating the risk of progression. Conclusions: The present nomogram models are useful to identify COVID-19 patients with disease progression based on individual characteristics and immune response-related indicators. Patients at high risk for severe illness and poor outcomes from COVID-19 should be managed with intensive supportive care and appropriate therapeutic strategies. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Medical Virology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
